Row over drug in lethal injection may prevent Missouri execution
A court hearing is scheduled Tuesday in the federal lawsuit filed by inmate Michael Taylor against The Apothecary Shoppe, a compounding pharmacy in Tulsa. A court hearing is scheduled Tuesday in the federal lawsuit filed by inmate Michael Taylor against The Apothecary Shoppe, a compounding pharmacy in Tulsa that his attorneys said was providing a drug that could cause “inhumane pain” during his 26 February execution. In their lawsuit, Taylor’s attorneys alleged that Missouri turned to The Apothecary Shoppe to supply compounded pentobarbital because the only licensed manufacturer of the drug refuses to provide it for lethal injections. Taylor’s attorneys say the cloak of secrecy surrounding how Missouri obtains its execution drug and questions about loosely regulated compounding pharmacies raise concerns. The suit alleges that several recent executions in which compounded pentobarbital was used showed it would likely cause Taylor “severe, unnecessary, lingering and ultimately inhumane pain.” Execution drugs have become increasingly difficult to obtain because major drug makers have stopped selling pharmaceuticals for use in the death penalty.

Discover Related

Oklahoma attorneys say execution method is constitutional

House panel demands information on federal execution drug

Analysis: Mississippi reveals it has lethal injection drugs

Nebraska prisons head: State can’t buy execution drugs again

Plan would further restrict Arkansas execution drug info

Official: Firms won’t sell execution drugs to Arizona

Oklahoma executions on hold as US Supreme Court reviews drug

Opinion: A shroud of secrecy around executions: Is this the American way?

Oklahoma court delays executions over plan to change lethal drugs
